Industry Pipeline - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135


Weighing terminal
The IND560 weighing terminal from Mettler Toledo allows users to choose between conventional strain gauge or high-precision, electromagnetic-force restoration weighing technologies. The unit is compatible with direct program logic controllers such as Profibus and DeviceNet, as well as Ethernet communication interfaces and internal and external digital I/O control. An IP65-rated panel and IP69k heavy-washdown mounting are available options. Atlantic Scale Co., Nutley, NJ tel. 973.661.7090

Near-infrared analyzer
The MB3600-PH Fourier transform-near infrared analyzer was designed for quality assurance, quality control, research, and at-line process analytical technologies applications. The instrument is maintenance-free and features a user-friendly software interface that enables operations that comply with 21 CFR Part 11. It analyzes solid and liquid samples nondestructively. ABB, Québec, Canada tel. 418.877.2944

On-line TOC analysis
To help pharmaceutical companies improve quality and reduce costs, GE Analytical Instruments offers a science- and risk-based program for achieving real-time release of pharmaceutical water. The program streamlines a complex process and helps companies move total organic carbon (TOC) testing from the laboratory to the production floor in approximately six months. GE Analytical Instruments, Boulder, CO tel. 800.255.6964

Microbial identification
Accugenix provides leading-edge technologies for microbial identification and offers characterization services to the pharmaceutical industry. The company continuously updates its proprietary genotypic and proteotypic identification libraries to reflect current taxonomy and add newly described, relevant species. The company is registered with the US Food and Drug Administration. Accugenix, Newark, DE tel. 800.886.9654


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here